SCHEMBL4778022

SCHEMBL4778022

Cc1cc(-n2c(Cc3ccc(F)cc3Cl)nc(=O)c3ncn(C)c32)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 13/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOB P27338 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769786 0.89 LMNA (0.41) P2RX7MAPK1NPSR1L3MBTL1ALDH1A1
SCHEMBL4776024 0.89 POLB (0.38) L3MBTL1ALDH1A1LMNAHTTMEN1
SCHEMBL4511396 0.85 MAPK1 (0.43) P2RX7MAPK1NPSR1L3MBTL1ALDH1A1
SCHEMBL4518790 0.80 MAPK1 (0.39) MAPK1NPSR1MEN1KMT2ATP53
SCHEMBL4777997 0.78 TSHR (0.39) P2RX7ALDH1A1LMNAKMT2AMAOB
SCHEMBL4767309 0.76 BRD9 (0.35) HTTTP53
SCHEMBL4777218 0.76 CYP2C19 (0.33) LMNAMEN1KMT2A
SCHEMBL4521143 0.76 MAPK1 (0.44) MAPK1NPSR1L3MBTL1ALDH1A1LMNA
SCHEMBL4772408 0.75 TRPV4 (0.33) MAPK1L3MBTL1ALDH1A1LMNATP53
SCHEMBL4519094 0.75 MAPK1 (0.47) P2RX7MAPK1NPSR1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed